Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,62 USD | +0,59% | +0,63% | -36,54% |
Vakgebied
Aantal werknemers: 553
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Transformative Medicines
100,0
%
| 78 | 100,0 % | 9 | 100,0 % | -88,02% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 78 | 100,0 % | 9 | 100,0 % | -88,02% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 01-01-15 |
Charles Homcy
FOU | Founder | 75 | 01-01-15 |
Founder | 73 | 01-01-15 | |
Brian Stephenson
DFI | Director of Finance/CFO | 43 | 01-10-18 |
Jonathan Fox
PSD | President | 67 | - |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-04-16 |
Christine Siu
COO | Chief Operating Officer | 47 | 01-01-20 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Vikram Bali
IRC | Investor Relations Contact | - | - |
Adora Ndu
LAW | General Counsel | 43 | 01-01-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 01-03-16 |
Founder | 73 | 01-01-15 | |
Fred Hassan
BRD | Director/Board Member | 78 | 17-08-21 |
Charles Homcy
FOU | Founder | 75 | 01-01-15 |
Randal Scott
BRD | Director/Board Member | 66 | 23-06-20 |
Richard Scheller
CTO | Chief Tech/Sci/R&D Officer | 70 | - |
Douglas Dachille
BRD | Director/Board Member | 59 | 17-08-21 |
Ali Satvat
BRD | Director/Board Member | 46 | 01-03-16 |
Andrew Lo
FOU | Founder | 63 | 01-01-15 |
Neil Kumar
FOU | Founder | 45 | 01-01-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 193 321 021 | 144 456 085 ( 74,72 %) | 6 191 761 ( 3,203 %) | 74,72 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
LIANBIO 4.75% | 5 002 792 | 4.75% | 1 615 902 $ |
Bedrijfsgegevens
BridgeBio Pharma, Inc.
3160 Porter Drive Suite 250
94304, Palo Alto
+650 391 9740
http://www.bridgebio.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-36,54% | 4,77 mld. | |
-4,20% | 87,17 mld. | |
+2,76% | 40,1 mld. | |
-16,98% | 31,38 mld. | |
+57,86% | 25,12 mld. | |
-16,24% | 15,59 mld. | |
-9,12% | 12 mld. | |
-42,56% | 11,8 mld. | |
-17,10% | 11,8 mld. | |
+6,89% | 8,81 mld. |
- Beurs
- Aandelen
- Koers BBIO
- Onderneming BridgeBio Pharma, Inc.